Artigo Revisado por pares

Effects of Irbesartan on Cloned Potassium Channels Involved in Human Cardiac Repolarization

2003; American Society for Pharmacology and Experimental Therapeutics; Volume: 304; Issue: 2 Linguagem: Inglês

10.1124/jpet.102.042325

ISSN

1521-0103

Autores

Ignacio Moreno, Ricardo Caballero, Teresa González, Cristina Arias, Carmen Valenzuela, Isabel Iriepa, Enrique J. Galvez, Juan Tamargo, Eva Delpón,

Tópico(s)

Receptor Mechanisms and Signaling

Resumo

We studied the effects of irbesartan, a selective angiotensin II type 1 receptor antagonist, on human ether-a-go-go -related gene (HERG), KvLQT1+minK, hKv1.5, and Kv4.3 channels using the patch-clamp technique. Irbesartan exhibited a low affinity for HERG and KvLQT1+minK channels (IC 50 = 193.0 ± 49.8 and 314.6 ± 85.4 μM, respectively). In hKv1.5 channels, irbesartan produced two types of block, depending on the concentration tested. At 0.1 μM, irbesartan inhibited the current in a time-dependent manner (22 ± 3.9% at +60 mV). The blockade increased steeply with channel activation increasing at more positive potentials. However, at 10 μM, irbesartan induced a time-independent blockade that occurred in the range of potentials of channel opening, reaching its maximum at ≈0 mV, and remaining unchanged at more positive potentials (24.0 ± 1.0% at +60 mV). In Kv4.3 currents, irbesartan produced a concentration-dependent block, which resulted in two IC 50 values (1.0 ± 0.1 nM and 7.2 ± 0.6 μM). At 1 μM, it inhibited the peak current and accelerated the time course of inactivation, decreasing the total charge crossing the membrane (36.6 ± 7.8% at +50 mV). Irbesartan shifted the inactivation curve of Kv4.3 channels, the blockade increasing as the amount of inactivated channels increased. Molecular modeling was used to define energy-minimized dockings of irbesartan to hKv1.5 and HERG channels. In conclusion, irbesartan blocks Kv4.3 and hKv1.5 channels at therapeutic concentrations, whereas the blockade of HERG and KvLQT1+minK channels occurred only at supratherapeutic levels. In hKv1.5, a receptor site is apparent on each α-subunit of the channel, whereas in HERG channels a common binding site is present at the pore.

Referência(s)